Essential updates 2018/2019: Current topics in the surgical treatment of pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is highly malignant. While cancers in other organs have shown clear improvements in 5‐year survival, the 5‐year survival rate of pancreatic cancer is approximately 10%. Early relapse and metastasis are not uncommon, making it difficult to achieve an acceptable...
Saved in:
| Published in | Annals of gastroenterological surgery Vol. 5; no. 1; pp. 7 - 23 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Japan
John Wiley & Sons, Inc
01.01.2021
John Wiley and Sons Inc Wiley |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2475-0328 2475-0328 |
| DOI | 10.1002/ags3.12379 |
Cover
| Abstract | Pancreatic ductal adenocarcinoma (PDAC) is highly malignant. While cancers in other organs have shown clear improvements in 5‐year survival, the 5‐year survival rate of pancreatic cancer is approximately 10%. Early relapse and metastasis are not uncommon, making it difficult to achieve an acceptable prognosis even after complete surgical resection of the pancreas. Studies have been performed on various treatments to improve the prognosis of PDAC, and multidisciplinary approaches including non‐surgical treatments have led to gradual improvement. In the present literature review, we have described the significance of anatomical and biological resectability criteria, the concept of R0 resection in surgical treatment, the feasibility of minimally invasive surgery, the remarkable development of perioperative chemotherapy, the effectiveness of conversion surgery for unresectable PDAC, and ongoing challenges in PDAC treatment. We also provide an essential update on these subjects by focusing on recent trends and topics.
In the present literature review, we have described the significance of anatomical and biological resectability criteria, the concept of R0 resection in surgical treatment, the feasibility of minimally invasive surgery, the remarkable development of perioperative chemotherapy, the effectiveness of conversion surgery for unresectable pancreatic cancer, and ongoing challenges in pancreatic cancer treatment. We also provide an essential update on these subjects by focusing on recent trends and topics. |
|---|---|
| AbstractList | Pancreatic ductal adenocarcinoma (PDAC) is highly malignant. While cancers in other organs have shown clear improvements in 5-year survival, the 5-year survival rate of pancreatic cancer is approximately 10%. Early relapse and metastasis are not uncommon, making it difficult to achieve an acceptable prognosis even after complete surgical resection of the pancreas. Studies have been performed on various treatments to improve the prognosis of PDAC, and multidisciplinary approaches including non-surgical treatments have led to gradual improvement. In the present literature review, we have described the significance of anatomical and biological resectability criteria, the concept of R0 resection in surgical treatment, the feasibility of minimally invasive surgery, the remarkable development of perioperative chemotherapy, the effectiveness of conversion surgery for unresectable PDAC, and ongoing challenges in PDAC treatment. We also provide an essential update on these subjects by focusing on recent trends and topics. Pancreatic ductal adenocarcinoma (PDAC) is highly malignant. While cancers in other organs have shown clear improvements in 5‐year survival, the 5‐year survival rate of pancreatic cancer is approximately 10%. Early relapse and metastasis are not uncommon, making it difficult to achieve an acceptable prognosis even after complete surgical resection of the pancreas. Studies have been performed on various treatments to improve the prognosis of PDAC, and multidisciplinary approaches including non‐surgical treatments have led to gradual improvement. In the present literature review, we have described the significance of anatomical and biological resectability criteria, the concept of R0 resection in surgical treatment, the feasibility of minimally invasive surgery, the remarkable development of perioperative chemotherapy, the effectiveness of conversion surgery for unresectable PDAC, and ongoing challenges in PDAC treatment. We also provide an essential update on these subjects by focusing on recent trends and topics. In the present literature review, we have described the significance of anatomical and biological resectability criteria, the concept of R0 resection in surgical treatment, the feasibility of minimally invasive surgery, the remarkable development of perioperative chemotherapy, the effectiveness of conversion surgery for unresectable pancreatic cancer, and ongoing challenges in pancreatic cancer treatment. We also provide an essential update on these subjects by focusing on recent trends and topics. Pancreatic ductal adenocarcinoma (PDAC) is highly malignant. While cancers in other organs have shown clear improvements in 5-year survival, the 5-year survival rate of pancreatic cancer is approximately 10%. Early relapse and metastasis are not uncommon, making it difficult to achieve an acceptable prognosis even after complete surgical resection of the pancreas. Studies have been performed on various treatments to improve the prognosis of PDAC, and multidisciplinary approaches including non-surgical treatments have led to gradual improvement. In the present literature review, we have described the significance of anatomical and biological resectability criteria, the concept of R0 resection in surgical treatment, the feasibility of minimally invasive surgery, the remarkable development of perioperative chemotherapy, the effectiveness of conversion surgery for unresectable PDAC, and ongoing challenges in PDAC treatment. We also provide an essential update on these subjects by focusing on recent trends and topics.Pancreatic ductal adenocarcinoma (PDAC) is highly malignant. While cancers in other organs have shown clear improvements in 5-year survival, the 5-year survival rate of pancreatic cancer is approximately 10%. Early relapse and metastasis are not uncommon, making it difficult to achieve an acceptable prognosis even after complete surgical resection of the pancreas. Studies have been performed on various treatments to improve the prognosis of PDAC, and multidisciplinary approaches including non-surgical treatments have led to gradual improvement. In the present literature review, we have described the significance of anatomical and biological resectability criteria, the concept of R0 resection in surgical treatment, the feasibility of minimally invasive surgery, the remarkable development of perioperative chemotherapy, the effectiveness of conversion surgery for unresectable PDAC, and ongoing challenges in PDAC treatment. We also provide an essential update on these subjects by focusing on recent trends and topics. Abstract Pancreatic ductal adenocarcinoma (PDAC) is highly malignant. While cancers in other organs have shown clear improvements in 5‐year survival, the 5‐year survival rate of pancreatic cancer is approximately 10%. Early relapse and metastasis are not uncommon, making it difficult to achieve an acceptable prognosis even after complete surgical resection of the pancreas. Studies have been performed on various treatments to improve the prognosis of PDAC, and multidisciplinary approaches including non‐surgical treatments have led to gradual improvement. In the present literature review, we have described the significance of anatomical and biological resectability criteria, the concept of R0 resection in surgical treatment, the feasibility of minimally invasive surgery, the remarkable development of perioperative chemotherapy, the effectiveness of conversion surgery for unresectable PDAC, and ongoing challenges in PDAC treatment. We also provide an essential update on these subjects by focusing on recent trends and topics. |
| Author | Hakamada, Kenichi Wakiya, Taiichi Miura, Takuya Kimura, Norihisa Ishido, Keinosuke |
| AuthorAffiliation | 1 Department of Gastroenterological Surgery Hirosaki University Graduate School of Medicine Hirosaki Japan |
| AuthorAffiliation_xml | – name: 1 Department of Gastroenterological Surgery Hirosaki University Graduate School of Medicine Hirosaki Japan |
| Author_xml | – sequence: 1 givenname: Keinosuke orcidid: 0000-0002-0342-1199 surname: Ishido fullname: Ishido, Keinosuke email: k-ishido@hirosaki-u.ac.jp organization: Hirosaki University Graduate School of Medicine – sequence: 2 givenname: Kenichi surname: Hakamada fullname: Hakamada, Kenichi organization: Hirosaki University Graduate School of Medicine – sequence: 3 givenname: Norihisa surname: Kimura fullname: Kimura, Norihisa organization: Hirosaki University Graduate School of Medicine – sequence: 4 givenname: Takuya surname: Miura fullname: Miura, Takuya organization: Hirosaki University Graduate School of Medicine – sequence: 5 givenname: Taiichi orcidid: 0000-0003-3681-7736 surname: Wakiya fullname: Wakiya, Taiichi organization: Hirosaki University Graduate School of Medicine |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33532676$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kktLHTEUx4diqda66QcoA92UwtW8H10U5GKtILiwXYdM5sw1l5nkNplp8ds341hRKW5OHud3_pzX22ovxABV9R6jY4wQObGbTI8xoVK_qg4Ik3yFKFF7j-771VHOW4QQ1lgQTt9U-5RySoQUB5U_yxnC6G1fT7vWjpBrgrA6KUZ_qddTSsVbj3HnXa59qMcbqPOUNt6ViDGBHYcZiF29s8HNb-_qdnJjcdsWQnQ2OR_iYN9VrzvbZzi6Pw-rn9_Ofqy_ry6vzi_Wp5crJyjRK42UlrLpQDoMHKTEWkHLbceR1A0SVCGQjdCdcq7RpBWagFaOSQGyw8rRw-pi0W2j3Zpd8oNNtyZab-4-YtoYm0qWPRjdNMwCwxyIZrSY0h6nBOokEw5bXrS-Llq7qRmgdaXUZPsnok89wd-YTfxtpCq1iFng071Air8myKMZfHbQ9zZAnLIhTAnMhVaooB-fods4pVBaZYhUQjLKOXuRYkWFSCFEoT48zvsh4X9zL8DnBXAp5pyge0AwMvNemXmvzN1eFRg9g50fy6DjXLPv_x-Cl5A_vofbF8TN6fk1XWL-AlKs3LY |
| CitedBy_id | crossref_primary_10_1097_MPA_0000000000002323 crossref_primary_10_1002_ags3_12629 crossref_primary_10_1186_s12957_023_02909_x crossref_primary_10_1245_s10434_022_13024_8 crossref_primary_10_3390_cancers13246381 crossref_primary_10_2958_suizo_36_293 crossref_primary_10_1002_ags3_12655 crossref_primary_10_3919_jjsa_82_2283 crossref_primary_10_1002_ags3_12601 crossref_primary_10_1007_s00535_022_01898_0 crossref_primary_10_1002_ags3_12459 crossref_primary_10_1097_XCS_0000000000000808 crossref_primary_10_52927_jdcr_2023_11_1_1 crossref_primary_10_1002_jhbp_1355 crossref_primary_10_1245_s10434_022_12985_0 crossref_primary_10_1080_02656736_2023_2278417 crossref_primary_10_14701_ahbps_2021_25_4_451 crossref_primary_10_3390_cancers14112577 crossref_primary_10_1038_s41598_022_12658_8 crossref_primary_10_1002_ags3_70012 crossref_primary_10_1186_s12871_021_01551_y crossref_primary_10_1245_s10434_021_10866_6 crossref_primary_10_1007_s10147_021_01983_z |
| Cites_doi | 10.1200/JCO.19.00946 10.1097/SLA.0000000000002111 10.1097/MPA.0000000000001231 10.1097/SLA.0000000000003717 10.1097/SLA.0000000000003301 10.1111/ans.14131 10.1097/MPA.0000000000001066 10.1016/j.hpb.2017.12.004 10.1002/jso.23921 10.1016/j.surg.2012.05.029 10.1007/s11605-016-3256-2 10.1001/jama.2010.1275 10.1056/NEJMoa1304369 10.1016/j.surg.2019.12.008 10.1002/ags3.12295 10.1007/s11033-020-05245-5 10.1097/SLA.0000000000001850 10.1016/j.gene.2018.09.029 10.1001/jamasurg.2019.2277 10.1097/SLA.0000000000002432 10.1002/cam4.1071 10.1016/j.ijsu.2018.05.026 10.1016/j.hpb.2020.01.001 10.1016/j.pan.2017.11.011 10.1016/j.amjsurg.2016.10.030 10.1200/JCO.2019.37.15_suppl.4000 10.1016/j.surg.2018.01.017 10.1097/SLA.0000000000002557 10.1002/bjs.10782 10.1007/s11605‐020‐04601‐x 10.1007/s00268-016-3412-6 10.1002/cncr.29112 10.1097/SLA.0b013e318263da2f 10.1097/SLA.0000000000000937 10.1007/s00464-020-07564-x 10.1186/s12885-019-5460-4 10.1097/SLA.0000000000000384 10.1007/s00268-018-4814-4 10.1002/bjs.10842 10.1186/s12885-019-6001-x 10.1186/s40880-019-0410-8 10.1002/bjs.11554 10.1016/j.ejso.2016.06.398 10.1097/SLA.0000000000002563 10.1007/s00464-017-5915-0 10.1245/s10434-018-6512-8 10.1097/SLA.0000000000001869 10.1245/s10434-017-6076-z 10.3389/fonc.2020.00500 10.1245/s10434-017-6290-8 10.1016/j.asjsur.2017.09.003 10.1016/j.surg.2016.08.040 10.1373/clinchem.2015.248260 10.1245/s10434-016-5707-0 10.1007/s00464-015-4444-y 10.1002/jso.25170 10.1001/jama.297.3.267 10.1038/s41598-019-52167-9 10.1007/s11605-019-04209-w 10.1097/MPA.0000000000001203 10.1186/s12885-018-4663-4 10.1016/S0140-6736(16)32409-6 10.1007/s00464-019-07047-8 10.3322/caac.21387 10.1016/j.hpb.2019.06.012 10.1097/MPA.0000000000001230 10.1007/s00464-017-5633-7 10.1007/s00330-019-06140-9 10.1097/MPA.0000000000001339 10.1097/SLA.0000000000002925 10.1097/SLA.0000000000003590 10.1016/j.suronc.2017.08.003 10.1002/bjs.11115 10.1056/NEJMoa1011923 10.1007/s00534-013-0616-0 10.1097/SLA.0000000000001705 10.1158/0008-5472.CAN-14-0155 10.1001/jama.2013.279201 10.1097/SLA.0000000000002561 10.1007/s00595-019-01786-w 10.1200/JCO.1997.15.6.2403 10.1007/s11701-019-01018-w 10.1016/j.jamcollsurg.2009.12.033 10.1200/JCO.2006.07.9525 10.1097/SLA.0000000000002753 10.1245/s10434-019-08087-z 10.1097/SLA.0000000000001479 10.1097/MPA.0000000000001146 10.1002/bjs.11147 10.5009/gnl18242 10.1016/j.amjsurg.2014.11.001 10.1016/j.surg.2018.04.017 10.1200/JCO.2008.20.5104 10.1245/s10434-018-07131-8 10.1200/JCO.2018.36.18_suppl.LBA4002 10.1016/j.jamcollsurg.2015.04.021 10.1007/s11605-018-3966-8 10.1093/annonc/mdx495 10.1097/MD.0000000000013592 10.1002/jso.24676 10.1016/j.surg.2019.05.010 10.3390/cancers11070981 10.1097/SLA.0000000000002893 10.1002/cncr.29161 10.1007/s11605-017-3627-3 10.1159/000501428 10.1002/ags3.12254 10.1016/j.hpb.2018.01.001 10.1007/s00595-016-1420-7 10.1016/j.surg.2013.04.015 10.1097/SLA.0000000000003615 10.3390/cancers11060852 10.1186/s12957-019-1767-5 10.1097/SLA.0000000000002234 10.1245/s10434-012-2809-1 10.1097/00000658-200209000-00012 10.1186/s12893-017-0291-1 10.1245/s10434-018-6763-4 10.1093/jnci/djz073 10.1002/ags3.12311 10.1002/1878-0261.12398 10.1007/s00464-016-5222-1 10.1093/annonc/mdv295 10.1245/s10434-011-2156-7 10.1308/rcsann.2019.0060 10.1186/1471-2407-11-346 10.1002/jhbp.119 10.1002/bjs.10662 10.1002/jso.25958 10.1186/s12876-015-0411-2 10.1200/JCO.2016.71.2273 10.1159/000494382 10.1097/MPA.0000000000001513 10.1200/JCO.2012.43.3680 10.3390/cancers11030278 10.1097/SLA.0000000000002979 10.1007/s11605-017-3506-y 10.1002/jhbp.648 10.1200/JCO.19.02274 10.1097/SLA.0000000000001600 10.1016/S0140-6736(16)30583-9 10.1007/s00595-019-01776-y 10.1007/s00268-013-2268-2 10.1177/000313481808400130 10.1002/jhbp.565 10.1097/SLA.0000000000001731 10.1200/JCO.2017.72.6463 10.1245/s10434-019-07602-6 10.1007/s00280-016-3199-z 10.1016/j.ejso.2019.08.007 10.1016/j.ejso.2019.03.039 10.1111/j.1365-2559.2009.03376.x 10.1002/bjs.10747 10.1097/MPA.0000000000001353 10.1097/SLA.0000000000002345 10.1016/j.jamcollsurg.2014.10.014 10.1056/NEJMoa1809775 10.1007/s00268-014-2808-4 10.1001/jamaoncol.2019.0892 10.1097/SLA.0000000000003270 10.1245/s10434-014-3898-9 10.1200/JCO.2019.37.4_suppl.189 10.1371/journal.pone.0212805 10.1016/j.ejso.2018.12.003 10.1631/jzus.B1600541 10.1007/s00534-011-0466-6 10.1016/j.jfma.2018.05.003 10.1097/SLA.0000000000002734 10.1016/j.pan.2018.07.001 10.1097/SLA.0000000000002600 10.1097/SLA.0000000000003284 10.1016/j.jamcollsurg.2016.02.009 10.1007/s00464-017-6002-2 10.1007/s00464-014-3507-9 10.1002/bjs.10870 10.1007/s00464-018-6301-2 10.1097/SLA.0000000000002705 10.1007/s11605-018-3972-x 10.1097/SLA.0000000000003468 10.1007/s00464-014-3537-3 10.1097/SLA.0000000000002810 10.1245/s10434-015-4647-4 10.1245/s10434-017-5885-4 10.3390/cancers12040982 10.1097/00000658-199810000-00007 10.1016/j.surg.2005.06.044 10.1016/j.surg.2016.08.005 10.3390/jcm9041129 10.1093/jjco/hyy033 10.1016/j.pan.2015.11.007 10.1097/SLA.0000000000003049 10.1097/SLA.0000000000001982 10.1001/jamasurg.2013.1673 10.1016/S2468-1253(19)30004-4 10.1016/j.asjsur.2018.08.011 |
| ContentType | Journal Article |
| Copyright | 2020 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterology 2020 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterology. 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2020 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterology – notice: 2020 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterology. – notice: 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | 24P AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1002/ags3.12379 |
| DatabaseName | Wiley Online Library Open Access CrossRef PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database PubMed MEDLINE - Academic CrossRef Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| DocumentTitleAlternate | ISHIDO et al |
| EISSN | 2475-0328 |
| EndPage | 23 |
| ExternalDocumentID | oai_doaj_org_article_9bb4ae415e2943e29625c860f746c1a5 PMC7832965 33532676 10_1002_ags3_12379 AGS312379 |
| Genre | reviewArticle Journal Article Review |
| GroupedDBID | 0R~ 1OC 24P 7X7 8FI 8FJ AAMMB ABUWG ACCMX ACGFS ACXQS ADBBV ADKYN ADPDF ADZMN AEFGJ AFKRA AGXDD AIDQK AIDYY ALMA_UNASSIGNED_HOLDINGS ALUQN AOIJS AVUZU BCNDV BENPR BPHCQ BVXVI CCPQU EBS EJD EMOBN FYUFA GROUPED_DOAJ HMCUK HYE IAO IHR INH ITC O9- OK1 OVD OVEED PHGZM PHGZT PIMPY PQQKQ PROAC RPM TEORI UKHRP WIN AAHHS AAYXX ACCFJ ADZOD AEEZP AEQDE AIWBW AJBDE ALIPV CITATION NPM 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c6329-908977bfe7c1e5e77198ed5af5079b06380e7b69f8ccb92d692e98c476e7f18c3 |
| IEDL.DBID | 24P |
| ISSN | 2475-0328 |
| IngestDate | Wed Aug 27 01:29:40 EDT 2025 Thu Aug 21 13:50:08 EDT 2025 Fri Sep 05 10:37:50 EDT 2025 Wed Aug 13 11:14:57 EDT 2025 Wed Aug 13 05:58:01 EDT 2025 Thu Apr 03 07:01:27 EDT 2025 Tue Jul 01 03:52:47 EDT 2025 Thu Apr 24 22:54:43 EDT 2025 Wed Aug 20 07:26:54 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | resectability criteria CA19‐9 conversion surgery minimally invasive pancreatectomy neoadjuvant treatment |
| Language | English |
| License | Attribution 2020 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterology. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c6329-908977bfe7c1e5e77198ed5af5079b06380e7b69f8ccb92d692e98c476e7f18c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0003-3681-7736 0000-0002-0342-1199 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fags3.12379 |
| PMID | 33532676 |
| PQID | 2480327666 |
| PQPubID | 4370315 |
| PageCount | 17 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_9bb4ae415e2943e29625c860f746c1a5 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7832965 proquest_miscellaneous_2486156980 proquest_journals_2786743554 proquest_journals_2480327666 pubmed_primary_33532676 crossref_primary_10_1002_ags3_12379 crossref_citationtrail_10_1002_ags3_12379 wiley_primary_10_1002_ags3_12379_AGS312379 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | January 2021 |
| PublicationDateYYYYMMDD | 2021-01-01 |
| PublicationDate_xml | – month: 01 year: 2021 text: January 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | Japan |
| PublicationPlace_xml | – name: Japan – name: Tokyo – name: Hoboken |
| PublicationTitle | Annals of gastroenterological surgery |
| PublicationTitleAlternate | Ann Gastroenterol Surg |
| PublicationYear | 2021 |
| Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc Wiley |
| Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc – name: Wiley |
| References | 2018; 164 2015; 262 2018; 163 2014; 259 2019; 11 2019; 13 2013; 369 2017; 87 2019; 14 2016; 388 2019; 19 2016; 30 2016; 264 2020; 14 2012; 19 2019; 18 2020; 167 2020; 12 2020; 10 2014; 28 2019; 166 2018; 48 2018; 47 2014; 21 2019; 24 2007; 297 2019; 23 2019; 26 2017; 79 2016; 42 2019; 29 2017; 161 2016; 40 2018; 32 2019; 270 2011; 364 2018; 36 2019; 154 2019; 9 2019; 4 2019; 3 2019; 5 2018; 105 2019; 33 2019; 37 2017; 67 2015; 121 2019; 39 2020; 38 2020; 37 2020; 34 2019; 106 2018; 22 2016; 16 2018; 20 2019; 101 2018; 25 2018; 18 2019; 42 2019; 43 2018; 118 2015; 111 2019; 45 2019; 48 2020; 271 2014; 38 2020; 27 2010; 210 2019; 49 2016; 20 2014; 260 2020; 22 2017; 265 2017; 266 2017; 389 2018; 97 2017; 6 2015; 39 2017; 47 2010; 304 2015; 221 2013; 20 2015; 220 2005; 138 2016; 223 2002; 236 2011; 11 2018; 84 2017; 116 2009; 55 2017; 31 2020; 4 1997; 15 2017; 35 2018; 379 2020; 9 2013; 310 2020; 49 2020; 47 2020; 46 2013; 154 2019; 118 2019; 111 2007; 25 2015; 15 2017; 26 2017; 28 2018; 267 2013; 148 2017; 21 2017; 24 2018; 268 2019; 269 2015; 209 2017; 213 2009; 27 2015; 26 2012; 152 2018; 271 2017; 17 2018; 679 2020 2013; 31 2015; 22 2019 1998; 228 2013; 257 2016; 62 2017 2016 2017; 18 2014; 74 2018; 55 2017; 104 2018; 59 e_1_2_7_3_1 e_1_2_7_104_1 e_1_2_7_127_1 e_1_2_7_19_1 e_1_2_7_60_1 e_1_2_7_83_1 e_1_2_7_191_1 e_1_2_7_11_1 e_1_2_7_45_1 e_1_2_7_68_1 e_1_2_7_142_1 e_1_2_7_165_1 e_1_2_7_188_1 e_1_2_7_116_1 e_1_2_7_94_1 e_1_2_7_71_1 e_1_2_7_180_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_79_1 e_1_2_7_131_1 e_1_2_7_154_1 e_1_2_7_177_1 e_1_2_7_139_1 e_1_2_7_4_1 e_1_2_7_128_1 e_1_2_7_105_1 e_1_2_7_82_1 e_1_2_7_120_1 e_1_2_7_192_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_67_1 e_1_2_7_143_1 e_1_2_7_189_1 e_1_2_7_29_1 e_1_2_7_166_1 e_1_2_7_117_1 e_1_2_7_70_1 e_1_2_7_93_1 e_1_2_7_181_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_78_1 e_1_2_7_193_1 e_1_2_7_132_1 e_1_2_7_155_1 e_1_2_7_178_1 e_1_2_7_106_1 e_1_2_7_129_1 e_1_2_7_9_1 e_1_2_7_81_1 e_1_2_7_121_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_66_1 e_1_2_7_170_1 e_1_2_7_89_1 e_1_2_7_182_1 e_1_2_7_28_1 e_1_2_7_144_1 e_1_2_7_167_1 e_1_2_7_118_1 e_1_2_7_110_1 e_1_2_7_92_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_77_1 e_1_2_7_54_1 e_1_2_7_171_1 e_1_2_7_194_1 e_1_2_7_39_1 e_1_2_7_133_1 e_1_2_7_156_1 e_1_2_7_179_1 e_1_2_7_107_1 e_1_2_7_80_1 e_1_2_7_122_1 e_1_2_7_2_1 e_1_2_7_14_1 e_1_2_7_42_1 e_1_2_7_88_1 e_1_2_7_65_1 e_1_2_7_160_1 e_1_2_7_183_1 e_1_2_7_27_1 e_1_2_7_145_1 e_1_2_7_168_1 Brierley JD (e_1_2_7_56_1) 2017 e_1_2_7_119_1 e_1_2_7_91_1 e_1_2_7_111_1 e_1_2_7_30_1 e_1_2_7_53_1 e_1_2_7_76_1 e_1_2_7_99_1 e_1_2_7_172_1 e_1_2_7_195_1 e_1_2_7_38_1 e_1_2_7_134_1 e_1_2_7_157_1 e_1_2_7_108_1 e_1_2_7_7_1 e_1_2_7_100_1 e_1_2_7_123_1 e_1_2_7_15_1 e_1_2_7_41_1 e_1_2_7_64_1 e_1_2_7_87_1 e_1_2_7_161_1 e_1_2_7_184_1 e_1_2_7_26_1 e_1_2_7_49_1 e_1_2_7_146_1 e_1_2_7_169_1 e_1_2_7_90_1 e_1_2_7_112_1 e_1_2_7_52_1 e_1_2_7_98_1 e_1_2_7_75_1 e_1_2_7_150_1 e_1_2_7_196_1 e_1_2_7_37_1 e_1_2_7_173_1 e_1_2_7_135_1 e_1_2_7_158_1 e_1_2_7_109_1 e_1_2_7_8_1 e_1_2_7_124_1 e_1_2_7_101_1 Society JP (e_1_2_7_57_1) 2017 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_63_1 e_1_2_7_86_1 e_1_2_7_185_1 e_1_2_7_48_1 e_1_2_7_162_1 e_1_2_7_147_1 Amin MB (e_1_2_7_55_1) 2016 e_1_2_7_113_1 e_1_2_7_51_1 e_1_2_7_74_1 e_1_2_7_97_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_59_1 e_1_2_7_151_1 e_1_2_7_174_1 e_1_2_7_197_1 e_1_2_7_136_1 e_1_2_7_159_1 e_1_2_7_5_1 e_1_2_7_102_1 e_1_2_7_125_1 e_1_2_7_17_1 e_1_2_7_62_1 e_1_2_7_85_1 e_1_2_7_47_1 e_1_2_7_140_1 e_1_2_7_163_1 e_1_2_7_186_1 e_1_2_7_148_1 e_1_2_7_114_1 e_1_2_7_73_1 e_1_2_7_50_1 e_1_2_7_96_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_58_1 e_1_2_7_152_1 e_1_2_7_175_1 e_1_2_7_198_1 e_1_2_7_137_1 e_1_2_7_6_1 e_1_2_7_126_1 e_1_2_7_103_1 e_1_2_7_18_1 e_1_2_7_84_1 e_1_2_7_61_1 e_1_2_7_190_1 e_1_2_7_10_1 e_1_2_7_46_1 e_1_2_7_69_1 e_1_2_7_141_1 e_1_2_7_164_1 e_1_2_7_187_1 e_1_2_7_149_1 e_1_2_7_115_1 e_1_2_7_72_1 e_1_2_7_95_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_130_1 e_1_2_7_153_1 e_1_2_7_176_1 e_1_2_7_199_1 e_1_2_7_138_1 |
| References_xml | – volume: 20 start-page: 1830 issue: 11 year: 2016 end-page: 5 article-title: Primary Tumor Resection Following Favorable Response to Systemic Chemotherapy in Stage IV Pancreatic Adenocarcinoma with Synchronous Metastases: a Bi‐institutional Analysis publication-title: J Gastrointest Surg – volume: 116 start-page: 461 issue: 4 year: 2017 end-page: 9 article-title: Robotic versus laparoscopic distal pancreatectomy: A propensity score‐matched study publication-title: J Surg Oncol – volume: 22 start-page: 224 issue: 2 year: 2020 end-page: 32 article-title: Induction chemotherapy in pancreatic cancer: CA 19–9 may predict resectability and survival publication-title: HPB (Oxford) – volume: 269 start-page: 1154 issue: 6 year: 2019 end-page: 62 article-title: Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma publication-title: Ann Surg – volume: 18 start-page: 2 issue: 1 year: 2018 end-page: 11 article-title: International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017 publication-title: Pancreatology – volume: 13 start-page: 356 issue: 3 year: 2019 end-page: 65 article-title: Preoperative Metabolic Tumor Volume2.5 Associated with Early Systemic Metastasis in Resected Pancreatic Cancer: A Transcriptome‐Wide Analysis publication-title: Gut Liver – year: 2020 article-title: Comparison of the duration of hospital stay after laparoscopic or open distal pancreatectomy: randomized controlled trial publication-title: Br J Surg – volume: 40 start-page: 1477 issue: 6 year: 2016 end-page: 84 article-title: Laparoscopic Versus Open Distal Pancreatectomy for Pancreatic Adenocarcinoma publication-title: World J Surg – volume: 20 start-page: 2188 issue: 7 year: 2013 end-page: 96 article-title: CA19‐9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy publication-title: Ann Surg Oncol – year: 2019 article-title: APACT: Phase III, multicenter, international, open‐label, randomized trial of adjuvant nab‐paclitaxel plus gemcitabine vs gemcitabine for surgically resected pancreatic adenocarcinoma publication-title: J Clin Oncol – volume: 22 start-page: 3512 issue: 11 year: 2015 end-page: 21 article-title: FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma publication-title: Ann Surg Oncol – volume: 304 start-page: 1073 issue: 10 year: 2010 end-page: 81 article-title: Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial publication-title: JAMA – volume: 25 start-page: 1896 issue: 7 year: 2018 end-page: 903 article-title: FOLFIRINOX Versus Gemcitabine/Nab‐Paclitaxel for Neoadjuvant Treatment of Resectable and Borderline Resectable Pancreatic Head Adenocarcinoma publication-title: Ann Surg Oncol – volume: 264 start-page: 457 issue: 3 year: 2016 end-page: 63 article-title: Locally Advanced Pancreatic Cancer: Neoadjuvant Therapy With Folfirinox Results in Resectability in 60% of the Patients publication-title: Ann Surg – volume: 270 start-page: 1147 issue: 6 year: 2019 end-page: 55 article-title: Comparing Short‐term and Oncologic Outcomes of Minimally Invasive Versus Open Pancreaticoduodenectomy Across Low and High Volume Centers publication-title: Ann Surg – volume: 25 start-page: 342 issue: 7 year: 2018 end-page: 50 article-title: Survival benefit of conversion surgery for patients with initially unresectable pancreatic cancer who responded favorably to nonsurgical treatment publication-title: J Hepatobiliary Pancreat Sci – year: 2019 article-title: Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer publication-title: Ann Surg – volume: 55 start-page: 277 issue: 3 year: 2009 end-page: 83 article-title: Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin publication-title: Histopathology – volume: 48 start-page: 823 issue: 6 year: 2019 end-page: 31 article-title: Does Neoadjuvant Chemotherapy Change the Role of Regional Lymphadenectomy in Pancreatic Cancer Survival? publication-title: Pancreas – volume: 28 start-page: 2786 issue: 11 year: 2017 end-page: 92 article-title: Selecting patients for resection after primary chemotherapy for non‐metastatic pancreatic adenocarcinoma publication-title: Ann Oncol – volume: 28 start-page: 2848 issue: 10 year: 2014 end-page: 55 article-title: Minimally invasive RAMPS in well‐selected left‐sided pancreatic cancer within Yonsei criteria: long‐term (>median 3 years) oncologic outcomes publication-title: Surg Endosc – volume: 138 start-page: 618 issue: 4 year: 2005 end-page: 28 article-title: A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma publication-title: Surgery – volume: 32 start-page: 2907 issue: 6 year: 2018 end-page: 13 article-title: Robotic‐assisted versus laparoscopic pancreaticoduodenectomy: oncological outcomes publication-title: Surg Endosc – volume: 104 start-page: 1443 issue: 11 year: 2017 end-page: 50 article-title: Randomized clinical trial of laparoscopic versus open pancreatoduodenectomy for periampullary tumours publication-title: Br J Surg – volume: 228 start-page: 508 issue: 4 year: 1998 end-page: 17 article-title: Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group publication-title: Ann Surg – volume: 43 start-page: 634 issue: 2 year: 2019 end-page: 41 article-title: Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19–9 is High‐Risk Stigmata for Primary Hepatic Recurrence in Patients with Curatively Resected Pancreatic Adenocarcinoma publication-title: World J Surg – volume: 369 start-page: 1691 issue: 18 year: 2013 end-page: 703 article-title: Increased survival in pancreatic cancer with nab‐paclitaxel plus gemcitabine publication-title: N Engl J Med – volume: 15 start-page: 182 year: 2015 article-title: LDP vs ODP for pancreatic adenocarcinoma: a case matched study from a single‐institution publication-title: BMC Gastroenterol – volume: 4 start-page: 100 issue: 2 year: 2020 end-page: 8 article-title: Neoadjuvant treatment for resectable pancreatic adenocarcinoma: What is the best protocol? publication-title: Ann Gastroenterol Surg – volume: 679 start-page: 328 year: 2018 end-page: 34 article-title: Prognostic value of circulating cell‐free DNA in patients with pancreatic cancer: A systemic review and meta‐analysis publication-title: Gene – volume: 31 start-page: 2233 issue: 5 year: 2017 end-page: 41 article-title: Laparoscopic versus open pancreaticoduodenectomy for pancreatic adenocarcinoma: long‐term results at a single institution publication-title: Surg Endosc – volume: 267 start-page: 936 issue: 5 year: 2018 end-page: 45 article-title: Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma publication-title: Ann Surg – volume: 260 start-page: 633 issue: 4 year: 2014 end-page: 8 article-title: Total laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic advantages over open approaches? publication-title: Ann Surg – volume: 267 start-page: 552 issue: 3 year: 2018 end-page: 60 article-title: Open Pancreaticoduodenectomy Case Volume Predicts Outcome of Laparoscopic Approach: A Population‐based Analysis publication-title: Ann Surg – volume: 35 start-page: 3330 issue: 29 year: 2017 end-page: 7 article-title: CONKO‐005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial publication-title: J Clin Oncol – volume: 42 start-page: 32 issue: 1 year: 2019 end-page: 45 article-title: Comparison of surgical outcomes of robot‐assisted laparoscopic distal pancreatectomy versus laparoscopic and open resections: A systematic review and meta‐analysis publication-title: Asian J Surg – volume: 106 start-page: 910 issue: 7 year: 2019 end-page: 21 article-title: Costs and quality of life in a randomized trial comparing minimally invasive and open distal pancreatectomy (LEOPARD trial) publication-title: Br J Surg – volume: 33 start-page: 234 issue: 1 year: 2019 end-page: 42 article-title: A propensity score‐matched analysis of robotic versus open pancreatoduodenectomy for pancreatic cancer based on margin status publication-title: Surg Endosc – volume: 47 start-page: 753 issue: 6 year: 2018 end-page: 8 article-title: A Therapeutic Strategy for Resectable Pancreatic Cancer Based on Risk Factors of Early Recurrence publication-title: Pancreas – volume: 271 start-page: 740 issue: 4 year: 2018 end-page: 7 article-title: Importance of Normalization of CA19‐9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer publication-title: Ann Surg – volume: 28 start-page: 2584 issue: 9 year: 2014 end-page: 91 article-title: Laparoscopic versus open distal splenopancreatectomy for the treatment of pancreatic body and tail cancer: a retrospective, mid‐term follow‐up study at a single academic tertiary care institution publication-title: Surg Endosc – volume: 30 start-page: 1778 issue: 5 year: 2016 end-page: 83 article-title: The First Decade of Laparoscopic Pancreaticoduodenectomy in the United States: Costs and Outcomes Using the Nationwide Inpatient Sample publication-title: Surg Endosc – volume: 21 start-page: 1620 issue: 10 year: 2017 end-page: 5 article-title: Laparoscopic Distal Pancreatectomy for Cancer Provides Oncologic Outcomes and Overall Survival Identical to Open Distal Pancreatectomy publication-title: J Gastrointest Surg – volume: 148 start-page: 525 issue: 6 year: 2013 end-page: 31 article-title: Comparative effectiveness of minimally invasive and open distal pancreatectomy for ductal adenocarcinoma publication-title: JAMA Surg – volume: 48 start-page: 1 issue: 1 year: 2019 end-page: 8 article-title: Emerging Evidence for the Clinical Relevance of Pancreatic Cancer Exosomes publication-title: Pancreas – volume: 23 start-page: 990 issue: 5 year: 2019 end-page: 6 article-title: A Preoperative Prognostic Scoring System to Predict Prognosis for Resectable Pancreatic Cancer: Who Will Benefit from Upfront Surgery? publication-title: J Gastrointest Surg – volume: 32 start-page: 53 issue: 1 year: 2018 end-page: 61 article-title: Laparoscopic distal pancreatectomy for pancreatic cancer is safe and effective publication-title: Surg Endosc – volume: 264 start-page: 640 issue: 4 year: 2016 end-page: 9 article-title: A Multi‐institutional Comparison of Perioperative Outcomes of Robotic and Open Pancreaticoduodenectomy publication-title: Ann Surg – volume: 31 start-page: 1640 issue: 13 year: 2013 end-page: 8 article-title: Randomized phase III study of gemcitabine plus S‐1, S‐1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study publication-title: J Clin Oncol – volume: 23 start-page: 112 issue: 1 year: 2019 end-page: 21 article-title: Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy publication-title: J Gastrointest Surg – volume: 268 start-page: 1058 issue: 6 year: 2018 end-page: 68 article-title: R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic Cancer publication-title: Ann Surg – year: 2019 article-title: Surgery Improves Survival After Neoadjuvant Therapy for Borderline and Locally Advanced Pancreatic Cancer: A Single Institution Experience publication-title: Ann Surg – volume: 268 start-page: 408 issue: 3 year: 2018 end-page: 20 article-title: Circulating Tumor Cells Dynamics in Pancreatic Adenocarcinoma Correlate With Disease Status: Results of the Prospective CLUSTER Study publication-title: Ann Surg – volume: 34 start-page: 3644 issue: 8 year: 2020 end-page: 49 article-title: Robotic pancreaticoduodenectomy may offer improved oncologic outcomes over open surgery: a propensity‐matched single‐institution study publication-title: Surgical Endoscopy – volume: 26 start-page: 4108 issue: 12 year: 2019 end-page: 16 article-title: Completion of Adjuvant Chemotherapy After Upfront Surgical Resection for Pancreatic Cancer Is Uncommon Yet Associated With Improved Survival publication-title: Ann Surg Oncol – volume: 24 start-page: 855 issue: 4 year: 2019 end-page: 65 article-title: Clinicopathological Features, Recurrence Patterns, and Prognosis of Pancreatic Adenocarcinoma with Normal Serum CA19‐9. A Consecutive Series of 154 Cases from a Single Institute publication-title: J Gastrointest Surg – volume: 268 start-page: 731 issue: 5 year: 2018 end-page: 9 article-title: Comparison of Perioperative Outcomes Between Laparoscopic and Open Approach for Pancreatoduodenectomy: The PADULAP Randomized Controlled Trial publication-title: Ann Surg – volume: 27 start-page: 2855 issue: 17 year: 2009 end-page: 62 article-title: Margin clearance and outcome in resected pancreatic cancer publication-title: J Clin Oncol – year: 2019 article-title: Outcomes of Elective and Emergency Conversion in Minimally Invasive Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: An International Multicenter Propensity Score‐matched Study publication-title: Ann Surg – volume: 38 start-page: 1763 issue: 16 year: 2020 end-page: 73 article-title: Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial publication-title: J Clin Oncol – volume: 6 start-page: 1201 issue: 6 year: 2017 end-page: 19 article-title: Neoadjuvant therapy in pancreatic cancer: a systematic review and meta‐analysis of prospective studies publication-title: Cancer Med – volume: 48 start-page: 199 issue: 2 year: 2019 end-page: 208 article-title: Global patterns and trends in pancreatic cancer incidence: age, period, and birth cohort analysis publication-title: Pancreas – volume: 46 start-page: 6 issue: 1 year: 2020 end-page: 14 article-title: Robotic versus conventional laparoscopic pancreaticoduodenectomy a systematic review and meta‐analysis publication-title: Eur J Surg Oncol – volume: 37 start-page: 229 issue: 3 year: 2020 end-page: 39 article-title: Robotic‐Assisted versus Laparoscopic Distal Pancreatectomy: The Results of a Case‐Matched Analysis from a Tertiary Care Center publication-title: Dig Surg – volume: 166 start-page: 277 issue: 3 year: 2019 end-page: 85 article-title: Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery publication-title: Surgery – volume: 42 start-page: 1533 issue: 10 year: 2016 end-page: 9 article-title: Is there a role for surgical resection in patients with pancreatic cancer with liver metastases responding to chemotherapy? publication-title: Eur J Surg Oncol – volume: 19 start-page: 781 issue: 1 year: 2019 article-title: Comparison of overall survival and perioperative outcomes of laparoscopic pancreaticoduodenectomy and open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a systematic review and meta‐analysis publication-title: BMC Cancer – volume: 74 start-page: 2913 issue: 11 year: 2014 end-page: 21 article-title: Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States publication-title: Cancer Res – volume: 389 start-page: 1011 issue: 10073 year: 2017 end-page: 24 article-title: Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC‐4): a multicentre, open‐label, randomised, phase 3 trial publication-title: Lancet – volume: 11 start-page: 852 issue: 6 year: 2019 article-title: Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma publication-title: Cancers (Basel) – volume: 34 start-page: 2465 issue: 6 year: 2020 end-page: 73 article-title: Robotic versus laparoscopic distal pancreatectomy for left‐sided pancreatic tumors: a single surgeon's experience of 228 consecutive cases publication-title: Surg Endosc – volume: 19 start-page: 230 issue: 3 year: 2012 end-page: 41 article-title: Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long‐term results of a Japanese multicenter randomized controlled trial publication-title: J Hepatobiliary Pancreat Sci – volume: 223 start-page: 52 issue: 1 year: 2016 end-page: 65 article-title: Carbohydrate Antigen 19–9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study publication-title: J Am Coll Surg – volume: 17 start-page: 94 issue: 1 year: 2017 article-title: Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial ‐ 1 (NorPACT‐1)) ‐ study protocol for a national multicentre randomized controlled trial publication-title: BMC Surg – volume: 39 start-page: 493 issue: 2 year: 2015 end-page: 9 article-title: Resection margin clearance in pancreatic cancer after implementation of the Leeds Pathology Protocol (LEEPP): clinically relevant or just academic? publication-title: World J Surg – volume: 49 start-page: 670 issue: 8 year: 2019 end-page: 7 article-title: Conversion surgery only for highly selected patients with unresectable pancreatic cancer: a satisfactory outcome in exchange for a lower resection rate publication-title: Surg Today – volume: 32 start-page: 2239 issue: 5 year: 2018 end-page: 48 article-title: Comparison of laparoscopic to open pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma publication-title: Surg Endosc – volume: 48 start-page: 913 issue: 7 year: 2019 end-page: 9 article-title: Induction Therapy in Localized Pancreatic Cancer publication-title: Pancreas – volume: 167 start-page: 803 issue: 5 year: 2020 end-page: 11 article-title: Impact of resection margin status on survival in pancreatic cancer patients after neoadjuvant treatment and pancreatoduodenectomy publication-title: Surgery – volume: 310 start-page: 1473 issue: 14 year: 2013 end-page: 81 article-title: Adjuvant chemotherapy with gemcitabine and long‐term outcomes among patients with resected pancreatic cancer: the CONKO‐001 randomized trial publication-title: JAMA – volume: 39 start-page: 66 issue: 1 year: 2019 article-title: Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matching analysis publication-title: Cancer Commun (Lond) – volume: 38 start-page: 476 issue: 2 year: 2014 end-page: 83 article-title: Oncological feasibility of laparoscopic distal pancreatectomy for adenocarcinoma: a single‐institution comparative study publication-title: World J Surg – volume: 18 start-page: 666 issue: 6 year: 2018 end-page: 70 article-title: CA 19–9 predicts resectability of pancreatic cancer even in jaundiced patients publication-title: Pancreatology – volume: 24 start-page: 1406 issue: 5 year: 2017 end-page: 13 article-title: Analysis of Predictors of Resection and Survival in Locally Advanced Stage III Pancreatic Cancer: Does the Nature of Chemotherapy Regimen Influence Outcomes? publication-title: Ann Surg Oncol – volume: 20 start-page: 573 issue: 6 year: 2018 end-page: 81 article-title: Neoadjuvant therapy affects margins and margins affect all: perioperative and survival outcomes in resected pancreatic adenocarcinoma publication-title: HPB (Oxford) – volume: 16 start-page: 28 issue: 1 year: 2016 end-page: 37 article-title: Neoadjuvant therapy for patients with borderline resectable pancreatic cancer: A systematic review and meta‐analysis of response and resection percentages publication-title: Pancreatology – volume: 21 start-page: 695 issue: 9 year: 2014 end-page: 702 article-title: Role of adjuvant surgery in initially unresectable pancreatic cancer after long‐term chemotherapy or chemoradiation therapy: survival benefit? publication-title: J Hepatobiliary Pancreat Sci – volume: 220 start-page: 177 issue: 2 year: 2015 end-page: 85 article-title: A comparative study of laparoscopic vs. open distal pancreatectomy for left‐sided ductal adenocarcinoma: a propensity score‐matched analysis publication-title: J Am Coll Surg – volume: 269 start-page: 733 issue: 4 year: 2019 end-page: 40 article-title: Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX publication-title: Ann Surg – volume: 48 start-page: 216 issue: 2 year: 2019 end-page: 22 article-title: Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Adjusted Analysis publication-title: Pancreas – volume: 15 start-page: 2403 issue: 6 year: 1997 end-page: 13 article-title: Improvements in survival and clinical benefit with gemcitabine as first‐line therapy for patients with advanced pancreas cancer: a randomized trial publication-title: J Clin Oncol – volume: 265 start-page: 397 issue: 2 year: 2017 end-page: 401 article-title: Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S‐1 for Pancreatic Ductal Adenocarcinoma Patients With Peritoneal Metastasis publication-title: Ann Surg – volume: 18 start-page: 1 issue: 1 year: 2019 article-title: Survival benefits of neoadjuvant chemo(radio)therapy versus surgery first in patients with resectable or borderline resectable pancreatic cancer: a systematic review and meta‐analysis publication-title: World J Surg Oncol – volume: 118 start-page: 268 issue: 1 Pt 2 year: 2019 end-page: 78 article-title: Do patients benefit more from robot assisted approach than conventional laparoscopic distal pancreatectomy? A meta‐analysis of perioperative and economic outcomes publication-title: J Formos Med Assoc – volume: 213 start-page: 512 issue: 3 year: 2017 end-page: 5 article-title: Laparoscopic pancreaticoduodenectomy for adenocarcinoma provides short‐term oncologic outcomes and long‐term overall survival rates similar to those for open pancreaticoduodenectomy publication-title: Am J Surg – volume: 26 start-page: 1629 issue: 6 year: 2019 end-page: 36 article-title: Clinical Impact of Neoadjuvant Chemotherapy and Chemoradiotherapy in Borderline Resectable Pancreatic Cancer: Analysis of 884 Patients at Facilities Specializing in Pancreatic Surgery publication-title: Ann Surg Oncol – volume: 388 start-page: 248 issue: 10041 year: 2016 end-page: 57 article-title: Adjuvant chemotherapy of S‐1 versus gemcitabine for resected pancreatic cancer: a phase 3, open‐label, randomised, non‐inferiority trial (JASPAC 01) publication-title: Lancet – volume: 48 start-page: 434 issue: 5 year: 2018 end-page: 41 article-title: 18F‐fluorodeoxyglucose positron emission tomography to indicate conversion surgery in patients with initially unresectable locally advanced pancreatic cancer publication-title: Jpn J Clin Oncol – volume: 161 start-page: 592 issue: 3 year: 2017 end-page: 601 article-title: Neoadjuvant therapy versus upfront surgery for resected pancreatic adenocarcinoma: A nationwide propensity score matched analysis publication-title: Surgery – volume: 14 issue: 2 year: 2019 article-title: Neoadjuvant therapy versus upfront surgery for potentially resectable pancreatic cancer: A Markov decision analysis publication-title: PLoS One – volume: 87 start-page: 987 issue: 12 year: 2017 end-page: 92 article-title: Serum carbohydrate antigen 19–9 in pancreatic adenocarcinoma: a mini review for surgeons publication-title: ANZ J Surg – volume: 105 start-page: 1171 issue: 9 year: 2018 end-page: 81 article-title: Validation of at least 1 mm as cut‐off for resection margins for pancreatic adenocarcinoma of the body and tail publication-title: Br J Surg – volume: 24 start-page: 2397 issue: 8 year: 2017 end-page: 403 article-title: Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? publication-title: Ann Surg Oncol – volume: 24 start-page: 3674 issue: 12 year: 2017 end-page: 82 article-title: Redefining the Positive Margin in Pancreatic Cancer: Impact on Patterns of Failure, Long‐Term Survival and Adjuvant Therapy publication-title: Ann Surg Oncol – volume: 121 start-page: 673 issue: 5 year: 2015 end-page: 80 article-title: Neoadjuvant gemcitabine, docetaxel, and capecitabine followed by gemcitabine and capecitabine/radiation therapy and surgery in locally advanced, unresectable pancreatic adenocarcinoma publication-title: Cancer – volume: 271 start-page: 1 issue: 1 year: 2020 end-page: 14 article-title: The Miami International Evidence‐based Guidelines on Minimally Invasive Pancreas Resection publication-title: Ann Surg – volume: 221 start-page: 175 issue: 1 year: 2015 end-page: 84 article-title: Early National Experience with Laparoscopic Pancreaticoduodenectomy for Ductal Adenocarcinoma: A Comparison of Laparoscopic Pancreaticoduodenectomy and Open Pancreaticoduodenectomy from the National Cancer Data Base publication-title: J Am Coll Surg – volume: 163 start-page: 1280 issue: 6 year: 2018 end-page: 94 article-title: A novel scoring system predicts postsurgical survival and adjuvant chemotherapeutic benefits in patients with pancreatic adenocarcinoma: Implications for AJCC‐TNM staging publication-title: Surgery – volume: 47 start-page: 1583 issue: 3 year: 2020 end-page: 8 article-title: CA19‐9 capability as predictor of pancreatic cancer resectability in a Spanish cohort publication-title: Mol Biol Rep – volume: 257 start-page: 731 issue: 4 year: 2013 end-page: 6 article-title: Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection? publication-title: Ann Surg – volume: 13 start-page: 212 issue: 2 year: 2019 end-page: 27 article-title: Circulating pancreatic cancer exosomal RNAs for detection of pancreatic cancer publication-title: Mol Oncol – volume: 106 start-page: 1055 issue: 8 year: 2019 end-page: 65 article-title: Impact of resection margin status on recurrence and survival in pancreatic cancer surgery publication-title: Br J Surg – volume: 154 start-page: 1078 issue: 5 year: 2013 end-page: 86 article-title: Margin status, recurrence pattern, and prognosis after resection of pancreatic cancer publication-title: Surgery – volume: 22 start-page: 279 issue: 2 year: 2018 end-page: 87 article-title: 18‐Fluorodeoxyglucose Positron Emission Tomography Predicts Recurrence in Resected Pancreatic Ductal Adenocarcinoma publication-title: J Gastrointest Surg – volume: 84 start-page: 109 issue: 1 year: 2018 end-page: 13 article-title: Span‐1 and CA19‐9 as Predictors of Early Recurrence and Lymph Node Metastasis for Patients with Invasive Pancreatic Cancer after Pancreatectomy publication-title: Am Surg – volume: 3 start-page: 368 issue: 4 year: 2019 end-page: 72 article-title: Cutting‐edge strategies for borderline resectable pancreatic cancer publication-title: Ann Gastroenterol Surg – volume: 19 start-page: 1663 issue: 5 year: 2012 end-page: 9 article-title: Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease publication-title: Ann Surg Oncol – volume: 27 start-page: 1191 issue: 4 year: 2020 end-page: 200 article-title: Neoadjuvant Therapy is Associated with Improved Survival in Borderline‐Resectable Pancreatic Cancer publication-title: Ann Surg Oncol – volume: 67 start-page: 7 issue: 1 year: 2017 end-page: 30 article-title: Cancer Statistics, 2017 publication-title: CA Cancer J Clin – volume: 259 start-page: 656 issue: 4 year: 2014 end-page: 64 article-title: A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer publication-title: Ann Surg – volume: 269 start-page: 520 issue: 3 year: 2019 end-page: 9 article-title: The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma publication-title: Ann Surg – volume: 37 start-page: 2082 year: 2019 end-page: 88 article-title: Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update publication-title: J Clin Oncol – volume: 4 start-page: 6 issue: 1 year: 2020 end-page: 13 article-title: Surgical indication for and desirable outcomes of conversion surgery in patients with initially unresectable pancreatic ductal adenocarcinoma publication-title: Ann Gastroenterol Surg – volume: 209 start-page: 557 issue: 3 year: 2015 end-page: 63 article-title: The laparoscopic approach to distal pancreatectomy for ductal adenocarcinoma results in shorter lengths of stay without compromising oncologic outcomes publication-title: Am J Surg – volume: 14 start-page: 493 issue: 3 year: 2020 end-page: 502 article-title: Robotic‐assisted versus open pancreaticoduodenectomy: the results of a case‐matched comparison publication-title: J Robot Surg – volume: 297 start-page: 267 issue: 3 year: 2007 end-page: 77 article-title: Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative‐intent resection of pancreatic cancer: a randomized controlled trial publication-title: JAMA – volume: 26 start-page: 402 issue: 4 year: 2017 end-page: 10 article-title: A comparative study of neoadjuvant treatment with gemcitabine plus nab‐paclitaxel versus surgery first for pancreatic adenocarcinoma publication-title: Surg Oncol – year: 2016 – volume: 18 start-page: 532 issue: 6 year: 2017 end-page: 8 article-title: Laparoscopic versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: a single‐center experience publication-title: J Zhejiang Univ Sci B – volume: 111 start-page: 1028 issue: 8 year: 2015 end-page: 34 article-title: Neoadjuvant modified FOLFIRINOX and chemoradiation therapy for locally advanced pancreatic cancer improves resectability publication-title: J Surg Oncol – volume: 264 start-page: 1073 issue: 6 year: 2016 end-page: 81 article-title: Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma publication-title: Ann Surg – volume: 152 start-page: S33 issue: 3 Suppl 1 year: 2012 end-page: 42 article-title: Resection after neoadjuvant therapy for locally advanced, "unresectable" pancreatic cancer publication-title: Surgery – volume: 49 start-page: 326 issue: 3 year: 2020 end-page: 35 article-title: Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society: A Synopsis publication-title: Pancreas – year: 2020 article-title: Long‐term oncologic outcomes of robotic and open pancreatectomy in a national cohort of pancreatic adenocarcinoma publication-title: J Surg Oncol – year: 2019 article-title: Oncologic Outcomes After Robotic Pancreatic Resections Are Not Inferior to Open Surgery publication-title: Ann Surg – volume: 26 start-page: 56 issue: Suppl 5 year: 2015 end-page: 68 article-title: Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow‐up publication-title: Ann Oncol – volume: 26 start-page: 416 issue: 9 year: 2019 end-page: 25 article-title: Role of surgical resection in the era of FOLFIRINOX for advanced pancreatic cancer publication-title: J Hepatobiliary Pancreat Sci – volume: 36 start-page: LBA4002 year: 2018 article-title: Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC‐ 1): a randomized, controlled multicener phase III trial publication-title: J Clin Oncol – year: 2019 article-title: Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer publication-title: Ann Surg – volume: 270 start-page: 340 issue: 2 year: 2019 end-page: 7 article-title: Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection publication-title: Ann Surg – volume: 59 start-page: 329 issue: 5–6 year: 2018 end-page: 38 article-title: Predictive Early Recurrence Factors of Preoperative Clinicophysiological Findings in Pancreatic Cancer publication-title: Eur Surg Res – volume: 379 start-page: 2395 issue: 25 year: 2018 end-page: 406 article-title: FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer publication-title: N Engl J Med – volume: 11 start-page: 346 year: 2011 article-title: Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study) publication-title: BMC Cancer – volume: 47 start-page: 1130 issue: 9 year: 2018 end-page: 4 article-title: Serum Marker Score Based on Prognostic Nutrition Index, Carcinoembryonic Antigen, and Carbohydrate Antigen 19–9 Is Associated With Recurrence for Patients Undergoing Surgery for Pancreatic Ductal Adenocarcinoma publication-title: Pancreas – volume: 12 start-page: 982 issue: 4 year: 2020 article-title: Comparison of Minimally Invasive versus Open Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Propensity Score Matching Analysis publication-title: Cancers (Basel) – year: 2020 article-title: Preoperative Chemotherapy for Pancreatic Cancer Improves Survival and R0 Rate Even in Early Stage I publication-title: J Gastrointest Surg – volume: 20 start-page: 590 issue: 6 year: 2013 end-page: 600 article-title: Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long‐term favorable response to non‐surgical anti‐cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery publication-title: J Hepatobiliary Pancreat Sci – volume: 164 start-page: 432 issue: 3 year: 2018 end-page: 42 article-title: Chronologic changes in clinical and survival features of pancreatic ductal adenocarcinoma since 2000: A single‐center experience with 2,029 patients publication-title: Surgery – volume: 265 start-page: 565 issue: 3 year: 2017 end-page: 73 article-title: Pancreatic Cancer Surgery: The New R‐status Counts publication-title: Ann Surg – volume: 269 start-page: 2 issue: 1 year: 2019 end-page: 9 article-title: Minimally Invasive Versus Open Distal Pancreatectomy (LEOPARD): A Multicenter Patient‐blinded Randomized Controlled Trial publication-title: Ann Surg – volume: 37 start-page: 189 issue: 4_suppl year: 2019 article-title: Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S‐1 versus upfront surgery for resectable pancreatic cancer (Prep‐02/JSAP‐05) publication-title: J Clin Oncol – volume: 269 start-page: 10 issue: 1 year: 2019 end-page: 17 article-title: Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA): A Pan‐European Propensity Score Matched Study publication-title: Ann Surg – volume: 29 start-page: 3714 issue: 7 year: 2019 end-page: 24 article-title: MDCT findings predicting post‐operative residual tumor and survival in patients with pancreatic cancer publication-title: Eur Radiol – volume: 266 start-page: 1055 issue: 6 year: 2017 end-page: 61 article-title: Nationwide Evaluation of Patient Selection for Minimally Invasive Distal Pancreatectomy Using American College of Surgeons' National Quality Improvement Program publication-title: Ann Surg – volume: 236 start-page: 355 issue: 3 year: 2002 end-page: 66 article-title: Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality publication-title: Ann Surg – volume: 154 start-page: 932 issue: 10 year: 2019 end-page: 42 article-title: Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma publication-title: JAMA Surg – volume: 9 start-page: 15662 issue: 1 year: 2019 article-title: Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer according to intention‐to‐treat and per‐protocol analysis: A systematic review and meta‐analysis publication-title: Sci Rep – volume: 22 start-page: 821 issue: 6 year: 2020 end-page: 32 article-title: Neoadjuvant chemotherapy for primary resectable pancreatic cancer: a systematic review and meta‐analysis publication-title: HPB – volume: 42 start-page: 93 issue: 1 year: 2019 end-page: 99 article-title: Clinical impact of margin status on survival and recurrence pattern after curative‐intent surgery for pancreatic cancer publication-title: Asian J Surg – volume: 35 start-page: 1623 issue: 14 year: 2017 article-title: Neoadjuvant Therapy in Resectable Pancreatic Cancer: Immortal Time Bias and Its Correction publication-title: J Clin Oncol – volume: 266 start-page: 787 issue: 5 year: 2017 end-page: 96 article-title: Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter Study publication-title: Ann Surg – volume: 268 start-page: 215 issue: 2 year: 2018 end-page: 22 article-title: Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer: A Prospective, Randomized, Open‐label, Multicenter Phase 2/3 Trial publication-title: Ann Surg – volume: 9 start-page: 1129 issue: 4 year: 2020 article-title: Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta‐Analysis of Randomized Controlled Trials publication-title: J Clin Med – volume: 18 start-page: 762 issue: 1 year: 2018 article-title: Resectable pancreatic adenocarcinoma neo‐adjuvant FOLF(IRIN)OX‐based chemotherapy ‐ a multicenter, non‐comparative, randomized, phase II trial (PANACHE01‐PRODIGE48 study) publication-title: BMC Cancer – volume: 11 start-page: 3 year: 2019 article-title: Clinical outcomes of conversion surgery after neoadjuvant chemotherapy in patients with borderline resectable and locally advanced unresectable pancreatic cancer: A single‐center, retrospective analysis publication-title: Cancers (Basel) – volume: 49 start-page: 295 issue: 4 year: 2019 end-page: 9 article-title: Long‐term outcome following neoadjuvant therapy for resectable and borderline resectable pancreatic cancer compared to upfront surgery: a meta‐analysis of comparative studies by intention‐to‐treat analysis publication-title: Surg Today – volume: 55 start-page: 162 year: 2018 end-page: 6 article-title: Oncological outcome of laparoscopically assisted pancreatoduodenectomy for ductal adenocarcinoma in a retrospective cohort study publication-title: Int J Surg – volume: 111 start-page: 782 issue: 8 year: 2019 end-page: 94 article-title: Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient‐Level Meta‐Analysis publication-title: J Natl Cancer Inst – volume: 19 start-page: 252 issue: 1 year: 2019 article-title: Decreased serum carbohydrate antigen 19–9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case‐control study of 240 patients publication-title: BMC Cancer – volume: 364 start-page: 1817 issue: 19 year: 2011 end-page: 25 article-title: FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer publication-title: N Engl J Med – volume: 62 start-page: 505 issue: 3 year: 2016 end-page: 13 article-title: Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma publication-title: Clin Chem – volume: 262 start-page: 868 issue: 5 year: 2015 end-page: 73 article-title: Laparoscopic Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: Time for a Randomized Controlled Trial? Results of an All‐inclusive National Observational Study publication-title: Ann Surg – volume: 22 start-page: 295 issue: 1 year: 2015 end-page: 301 article-title: FOLFIRINOX for locally advanced pancreatic adenocarcinoma: results of an AGEO multicenter prospective observational cohort publication-title: Ann Surg Oncol – volume: 45 start-page: 1453 issue: 8 year: 2019 end-page: 9 article-title: CT response of primary tumor and CA19‐9 predict resectability of metastasized pancreatic cancer after FOLFIRINOX publication-title: Eur J Surg Oncol – volume: 105 start-page: 946 issue: 8 year: 2018 end-page: 58 article-title: Meta‐analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer publication-title: Br J Surg – volume: 10 start-page: 500 year: 2020 article-title: Value of Pretreatment (18)F‐fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy publication-title: Front Oncol – volume: 4 start-page: 199 issue: 3 year: 2019 end-page: 207 article-title: Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD‐2): a multicentre, patient‐blinded, randomised controlled phase 2/3 trial publication-title: Lancet Gastroenterol Hepatol – volume: 25 start-page: 1960 issue: 15 year: 2007 end-page: 6 article-title: Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group publication-title: J Clin Oncol – volume: 45 start-page: 719 issue: 5 year: 2019 end-page: 27 article-title: Oncologic outcomes of minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: A systematic review and meta‐analysis publication-title: Eur J Surg Oncol – volume: 97 issue: 50 year: 2018 article-title: Clinical outcomes of FOLFIRINOX in locally advanced pancreatic cancer: A single center experience publication-title: Medicine (Baltimore) – volume: 20 start-page: 605 issue: 7 year: 2018 end-page: 11 article-title: Added value of CA19‐9 response in predicting resectability of locally advanced pancreatic cancer following induction chemotherapy publication-title: HPB (Oxford) – volume: 270 start-page: 400 issue: 3 year: 2019 end-page: 13 article-title: Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab‐Paclitaxel Chemotherapy in Resected Pancreatic Cancer publication-title: Ann Surg – volume: 25 start-page: 4004 issue: 13 year: 2018 end-page: 11 article-title: Clinical Implications of Extensive Lymph Node Metastases for Resected Pancreatic Cancer publication-title: Ann Surg Oncol – volume: 210 start-page: 779 issue: 5 year: 2010 end-page: 85 article-title: A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate? publication-title: J Am Coll Surg – volume: 105 start-page: 578 issue: 5 year: 2018 end-page: 86 article-title: Propensity score‐matched comparison of oncological outcomes between laparoscopic and open distal pancreatic resection publication-title: Br J Surg – volume: 79 start-page: 37 issue: 1 year: 2017 end-page: 47 article-title: Survival impact of neoadjuvant gemcitabine plus S‐1 chemotherapy for patients with borderline resectable pancreatic carcinoma with arterial contact publication-title: Cancer Chemother Pharmacol – volume: 47 start-page: 490 issue: 4 year: 2017 end-page: 7 article-title: The impact of margin status determined by the one‐millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma publication-title: Surg Today – volume: 121 start-page: 1128 issue: 7 year: 2015 end-page: 37 article-title: Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma publication-title: Cancer – volume: 161 start-page: 373 issue: 2 year: 2017 end-page: 84 article-title: Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19‐9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma publication-title: Surgery – volume: 269 start-page: 344 issue: 2 year: 2019 end-page: 50 article-title: Outcomes of a Multicenter Training Program in Laparoscopic Pancreatoduodenectomy (LAELAPS‐2) publication-title: Ann Surg – volume: 5 start-page: 1020 issue: 7 year: 2019 end-page: 7 article-title: Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial publication-title: JAMA Oncol – volume: 11 start-page: 981 issue: 7 year: 2019 article-title: Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single‐Center Experience and a Literature publication-title: Review. Cancers (Basel) – volume: 105 start-page: 110 issue: 2 year: 2018 end-page: 20 article-title: Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer publication-title: Br J Surg – year: 2017 – volume: 101 start-page: 453 issue: 7 year: 2019 end-page: 62 article-title: Systemic neoadjuvant chemotherapy in modern pancreatic cancer treatment: a systematic review and meta‐analysis publication-title: Ann R Coll Surg Engl – volume: 118 start-page: 651 issue: 4 year: 2018 end-page: 6 article-title: Oncologic outcomes after robot‐assisted versus laparoscopic distal pancreatectomy: Analysis of the National Cancer Database publication-title: J Surg Oncol – volume: 25 start-page: 1000 issue: 4 year: 2018 end-page: 8 article-title: Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer publication-title: Ann Surg Oncol – ident: e_1_2_7_7_1 doi: 10.1200/JCO.19.00946 – ident: e_1_2_7_107_1 doi: 10.1097/SLA.0000000000002111 – ident: e_1_2_7_146_1 doi: 10.1097/MPA.0000000000001231 – ident: e_1_2_7_123_1 doi: 10.1097/SLA.0000000000003717 – ident: e_1_2_7_191_1 doi: 10.1097/SLA.0000000000003301 – ident: e_1_2_7_11_1 doi: 10.1111/ans.14131 – ident: e_1_2_7_21_1 doi: 10.1097/MPA.0000000000001066 – ident: e_1_2_7_68_1 doi: 10.1016/j.hpb.2017.12.004 – ident: e_1_2_7_182_1 doi: 10.1002/jso.23921 – ident: e_1_2_7_176_1 doi: 10.1016/j.surg.2012.05.029 – ident: e_1_2_7_196_1 doi: 10.1007/s11605-016-3256-2 – ident: e_1_2_7_135_1 doi: 10.1001/jama.2010.1275 – ident: e_1_2_7_174_1 doi: 10.1056/NEJMoa1304369 – ident: e_1_2_7_71_1 doi: 10.1016/j.surg.2019.12.008 – ident: e_1_2_7_36_1 doi: 10.1002/ags3.12295 – ident: e_1_2_7_26_1 doi: 10.1007/s11033-020-05245-5 – ident: e_1_2_7_27_1 doi: 10.1097/SLA.0000000000001850 – ident: e_1_2_7_47_1 doi: 10.1016/j.gene.2018.09.029 – ident: e_1_2_7_193_1 doi: 10.1001/jamasurg.2019.2277 – ident: e_1_2_7_53_1 doi: 10.1097/SLA.0000000000002432 – ident: e_1_2_7_148_1 doi: 10.1002/cam4.1071 – ident: e_1_2_7_101_1 doi: 10.1016/j.ijsu.2018.05.026 – ident: e_1_2_7_155_1 doi: 10.1016/j.hpb.2020.01.001 – ident: e_1_2_7_20_1 doi: 10.1016/j.pan.2017.11.011 – ident: e_1_2_7_92_1 doi: 10.1016/j.amjsurg.2016.10.030 – ident: e_1_2_7_140_1 doi: 10.1200/JCO.2019.37.15_suppl.4000 – ident: e_1_2_7_14_1 doi: 10.1016/j.surg.2018.01.017 – ident: e_1_2_7_64_1 doi: 10.1097/SLA.0000000000002557 – ident: e_1_2_7_46_1 doi: 10.1002/bjs.10782 – ident: e_1_2_7_143_1 doi: 10.1007/s11605‐020‐04601‐x – ident: e_1_2_7_90_1 doi: 10.1007/s00268-016-3412-6 – ident: e_1_2_7_183_1 doi: 10.1002/cncr.29112 – ident: e_1_2_7_58_1 doi: 10.1097/SLA.0b013e318263da2f – ident: e_1_2_7_97_1 doi: 10.1097/SLA.0000000000000937 – ident: e_1_2_7_121_1 doi: 10.1007/s00464-020-07564-x – ident: e_1_2_7_31_1 doi: 10.1186/s12885-019-5460-4 – ident: e_1_2_7_128_1 doi: 10.1097/SLA.0000000000000384 – ident: e_1_2_7_18_1 doi: 10.1007/s00268-018-4814-4 – ident: e_1_2_7_62_1 doi: 10.1002/bjs.10842 – ident: e_1_2_7_105_1 doi: 10.1186/s12885-019-6001-x – ident: e_1_2_7_103_1 doi: 10.1186/s40880-019-0410-8 – ident: e_1_2_7_73_1 doi: 10.1002/bjs.11554 – ident: e_1_2_7_195_1 doi: 10.1016/j.ejso.2016.06.398 – ident: e_1_2_7_109_1 doi: 10.1097/SLA.0000000000002563 – ident: e_1_2_7_106_1 doi: 10.1007/s00464-017-5915-0 – ident: e_1_2_7_165_1 doi: 10.1245/s10434-018-6512-8 – ident: e_1_2_7_118_1 doi: 10.1097/SLA.0000000000001869 – ident: e_1_2_7_67_1 doi: 10.1245/s10434-017-6076-z – ident: e_1_2_7_41_1 doi: 10.3389/fonc.2020.00500 – ident: e_1_2_7_44_1 doi: 10.1245/s10434-017-6290-8 – ident: e_1_2_7_66_1 doi: 10.1016/j.asjsur.2017.09.003 – ident: e_1_2_7_145_1 doi: 10.1016/j.surg.2016.08.040 – ident: e_1_2_7_42_1 doi: 10.1373/clinchem.2015.248260 – ident: e_1_2_7_184_1 doi: 10.1245/s10434-016-5707-0 – ident: e_1_2_7_108_1 doi: 10.1007/s00464-015-4444-y – ident: e_1_2_7_94_1 doi: 10.1002/jso.25170 – ident: e_1_2_7_134_1 doi: 10.1001/jama.297.3.267 – ident: e_1_2_7_173_1 doi: 10.1038/s41598-019-52167-9 – ident: e_1_2_7_17_1 doi: 10.1007/s11605-019-04209-w – ident: e_1_2_7_49_1 doi: 10.1097/MPA.0000000000001203 – ident: e_1_2_7_161_1 doi: 10.1186/s12885-018-4663-4 – ident: e_1_2_7_137_1 doi: 10.1016/S0140-6736(16)32409-6 – ident: e_1_2_7_115_1 doi: 10.1007/s00464-019-07047-8 – ident: e_1_2_7_2_1 doi: 10.3322/caac.21387 – ident: e_1_2_7_33_1 doi: 10.1016/j.hpb.2019.06.012 – ident: e_1_2_7_3_1 doi: 10.1097/MPA.0000000000001230 – ident: e_1_2_7_93_1 doi: 10.1007/s00464-017-5633-7 – ident: e_1_2_7_6_1 doi: 10.1007/s00330-019-06140-9 – ident: e_1_2_7_142_1 doi: 10.1097/MPA.0000000000001339 – ident: e_1_2_7_45_1 doi: 10.1097/SLA.0000000000002925 – ident: e_1_2_7_72_1 doi: 10.1097/SLA.0000000000003590 – ident: e_1_2_7_168_1 doi: 10.1016/j.suronc.2017.08.003 – ident: e_1_2_7_65_1 doi: 10.1002/bjs.11115 – ident: e_1_2_7_131_1 doi: 10.1056/NEJMoa1011923 – ident: e_1_2_7_177_1 doi: 10.1007/s00534-013-0616-0 – ident: e_1_2_7_197_1 doi: 10.1097/SLA.0000000000001705 – ident: e_1_2_7_4_1 doi: 10.1158/0008-5472.CAN-14-0155 – ident: e_1_2_7_133_1 doi: 10.1001/jama.2013.279201 – ident: e_1_2_7_95_1 doi: 10.1097/SLA.0000000000002561 – ident: e_1_2_7_150_1 doi: 10.1007/s00595-019-01786-w – ident: e_1_2_7_129_1 doi: 10.1200/JCO.1997.15.6.2403 – ident: e_1_2_7_122_1 doi: 10.1007/s11701-019-01018-w – ident: e_1_2_7_81_1 doi: 10.1016/j.jamcollsurg.2009.12.033 – ident: e_1_2_7_130_1 doi: 10.1200/JCO.2006.07.9525 – ident: e_1_2_7_188_1 doi: 10.1097/SLA.0000000000002753 – ident: e_1_2_7_69_1 doi: 10.1245/s10434-019-08087-z – ident: e_1_2_7_88_1 doi: 10.1097/SLA.0000000000001479 – ident: e_1_2_7_12_1 doi: 10.1097/MPA.0000000000001146 – ident: e_1_2_7_74_1 doi: 10.1002/bjs.11147 – volume-title: UICC: TNM Classification of Malignant Tumors year: 2017 ident: e_1_2_7_56_1 – ident: e_1_2_7_40_1 doi: 10.5009/gnl18242 – ident: e_1_2_7_86_1 doi: 10.1016/j.amjsurg.2014.11.001 – ident: e_1_2_7_5_1 doi: 10.1016/j.surg.2018.04.017 – ident: e_1_2_7_51_1 doi: 10.1200/JCO.2008.20.5104 – ident: e_1_2_7_163_1 doi: 10.1245/s10434-018-07131-8 – ident: e_1_2_7_156_1 doi: 10.1200/JCO.2018.36.18_suppl.LBA4002 – ident: e_1_2_7_98_1 doi: 10.1016/j.jamcollsurg.2015.04.021 – ident: e_1_2_7_169_1 doi: 10.1007/s11605-018-3966-8 – ident: e_1_2_7_185_1 doi: 10.1093/annonc/mdx495 – ident: e_1_2_7_189_1 doi: 10.1097/MD.0000000000013592 – ident: e_1_2_7_112_1 doi: 10.1002/jso.24676 – ident: e_1_2_7_167_1 doi: 10.1016/j.surg.2019.05.010 – ident: e_1_2_7_194_1 doi: 10.3390/cancers11070981 – ident: e_1_2_7_78_1 doi: 10.1097/SLA.0000000000002893 – ident: e_1_2_7_179_1 doi: 10.1002/cncr.29161 – ident: e_1_2_7_39_1 doi: 10.1007/s11605-017-3627-3 – ident: e_1_2_7_116_1 doi: 10.1159/000501428 – ident: e_1_2_7_162_1 doi: 10.1002/ags3.12254 – ident: e_1_2_7_38_1 doi: 10.1016/j.hpb.2018.01.001 – ident: e_1_2_7_52_1 doi: 10.1007/s00595-016-1420-7 – ident: e_1_2_7_59_1 doi: 10.1016/j.surg.2013.04.015 – ident: e_1_2_7_114_1 doi: 10.1097/SLA.0000000000003615 – ident: e_1_2_7_48_1 doi: 10.3390/cancers11060852 – ident: e_1_2_7_154_1 doi: 10.1186/s12957-019-1767-5 – ident: e_1_2_7_10_1 doi: 10.1097/SLA.0000000000002234 – ident: e_1_2_7_28_1 doi: 10.1245/s10434-012-2809-1 – ident: e_1_2_7_125_1 doi: 10.1097/00000658-200209000-00012 – ident: e_1_2_7_160_1 doi: 10.1186/s12893-017-0291-1 – ident: e_1_2_7_13_1 doi: 10.1245/s10434-018-6763-4 – ident: e_1_2_7_151_1 doi: 10.1093/jnci/djz073 – ident: e_1_2_7_158_1 doi: 10.1002/ags3.12311 – ident: e_1_2_7_50_1 doi: 10.1002/1878-0261.12398 – ident: e_1_2_7_99_1 doi: 10.1007/s00464-016-5222-1 – ident: e_1_2_7_8_1 doi: 10.1093/annonc/mdv295 – ident: e_1_2_7_175_1 doi: 10.1245/s10434-011-2156-7 – ident: e_1_2_7_153_1 doi: 10.1308/rcsann.2019.0060 – ident: e_1_2_7_159_1 doi: 10.1186/1471-2407-11-346 – ident: e_1_2_7_178_1 doi: 10.1002/jhbp.119 – ident: e_1_2_7_77_1 doi: 10.1002/bjs.10662 – ident: e_1_2_7_117_1 doi: 10.1002/jso.25958 – ident: e_1_2_7_89_1 doi: 10.1186/s12876-015-0411-2 – ident: e_1_2_7_144_1 doi: 10.1200/JCO.2016.71.2273 – ident: e_1_2_7_23_1 doi: 10.1159/000494382 – ident: e_1_2_7_9_1 doi: 10.1097/MPA.0000000000001513 – ident: e_1_2_7_132_1 doi: 10.1200/JCO.2012.43.3680 – ident: e_1_2_7_190_1 doi: 10.3390/cancers11030278 – ident: e_1_2_7_75_1 doi: 10.1097/SLA.0000000000002979 – ident: e_1_2_7_100_1 doi: 10.1007/s11605-017-3506-y – ident: e_1_2_7_199_1 doi: 10.1002/jhbp.648 – ident: e_1_2_7_172_1 doi: 10.1200/JCO.19.02274 – ident: e_1_2_7_43_1 doi: 10.1097/SLA.0000000000001600 – ident: e_1_2_7_136_1 doi: 10.1016/S0140-6736(16)30583-9 – ident: e_1_2_7_187_1 doi: 10.1007/s00595-019-01776-y – ident: e_1_2_7_83_1 doi: 10.1007/s00268-013-2268-2 – ident: e_1_2_7_25_1 doi: 10.1177/000313481808400130 – ident: e_1_2_7_186_1 doi: 10.1002/jhbp.565 – volume-title: AJCC Cancer Staging Manual year: 2016 ident: e_1_2_7_55_1 – ident: e_1_2_7_61_1 doi: 10.1097/SLA.0000000000001731 – volume-title: Classification of Pancreatic Carcinoma 4th edition (Japanese 7th edition) year: 2017 ident: e_1_2_7_57_1 – ident: e_1_2_7_138_1 doi: 10.1200/JCO.2017.72.6463 – ident: e_1_2_7_141_1 doi: 10.1245/s10434-019-07602-6 – ident: e_1_2_7_166_1 doi: 10.1007/s00280-016-3199-z – ident: e_1_2_7_113_1 doi: 10.1016/j.ejso.2019.08.007 – ident: e_1_2_7_35_1 doi: 10.1016/j.ejso.2019.03.039 – ident: e_1_2_7_54_1 doi: 10.1111/j.1365-2559.2009.03376.x – ident: e_1_2_7_96_1 doi: 10.1002/bjs.10747 – ident: e_1_2_7_170_1 doi: 10.1097/MPA.0000000000001353 – ident: e_1_2_7_63_1 doi: 10.1097/SLA.0000000000002345 – ident: e_1_2_7_87_1 doi: 10.1016/j.jamcollsurg.2014.10.014 – ident: e_1_2_7_139_1 doi: 10.1056/NEJMoa1809775 – ident: e_1_2_7_60_1 doi: 10.1007/s00268-014-2808-4 – ident: e_1_2_7_192_1 doi: 10.1001/jamaoncol.2019.0892 – ident: e_1_2_7_34_1 doi: 10.1097/SLA.0000000000003270 – ident: e_1_2_7_181_1 doi: 10.1245/s10434-014-3898-9 – ident: e_1_2_7_157_1 doi: 10.1200/JCO.2019.37.4_suppl.189 – ident: e_1_2_7_152_1 doi: 10.1371/journal.pone.0212805 – ident: e_1_2_7_80_1 doi: 10.1016/j.ejso.2018.12.003 – ident: e_1_2_7_91_1 doi: 10.1631/jzus.B1600541 – ident: e_1_2_7_127_1 doi: 10.1007/s00534-011-0466-6 – ident: e_1_2_7_111_1 doi: 10.1016/j.jfma.2018.05.003 – ident: e_1_2_7_15_1 doi: 10.1097/SLA.0000000000002734 – ident: e_1_2_7_24_1 doi: 10.1016/j.pan.2018.07.001 – ident: e_1_2_7_30_1 doi: 10.1097/SLA.0000000000002600 – ident: e_1_2_7_32_1 doi: 10.1097/SLA.0000000000003284 – ident: e_1_2_7_19_1 doi: 10.1016/j.jamcollsurg.2016.02.009 – ident: e_1_2_7_119_1 doi: 10.1007/s00464-017-6002-2 – ident: e_1_2_7_85_1 doi: 10.1007/s00464-014-3507-9 – ident: e_1_2_7_149_1 doi: 10.1002/bjs.10870 – ident: e_1_2_7_120_1 doi: 10.1007/s00464-018-6301-2 – ident: e_1_2_7_171_1 doi: 10.1097/SLA.0000000000002705 – ident: e_1_2_7_22_1 doi: 10.1007/s11605-018-3972-x – ident: e_1_2_7_164_1 doi: 10.1097/SLA.0000000000003468 – ident: e_1_2_7_84_1 doi: 10.1007/s00464-014-3537-3 – ident: e_1_2_7_102_1 doi: 10.1097/SLA.0000000000002810 – ident: e_1_2_7_180_1 doi: 10.1245/s10434-015-4647-4 – ident: e_1_2_7_198_1 doi: 10.1245/s10434-017-5885-4 – ident: e_1_2_7_104_1 doi: 10.3390/cancers12040982 – ident: e_1_2_7_124_1 doi: 10.1097/00000658-199810000-00007 – ident: e_1_2_7_126_1 doi: 10.1016/j.surg.2005.06.044 – ident: e_1_2_7_16_1 doi: 10.1016/j.surg.2016.08.005 – ident: e_1_2_7_70_1 doi: 10.3390/jcm9041129 – ident: e_1_2_7_37_1 doi: 10.1093/jjco/hyy033 – ident: e_1_2_7_147_1 doi: 10.1016/j.pan.2015.11.007 – ident: e_1_2_7_29_1 doi: 10.1097/SLA.0000000000003049 – ident: e_1_2_7_76_1 doi: 10.1097/SLA.0000000000001982 – ident: e_1_2_7_82_1 doi: 10.1001/jamasurg.2013.1673 – ident: e_1_2_7_79_1 doi: 10.1016/S2468-1253(19)30004-4 – ident: e_1_2_7_110_1 doi: 10.1016/j.asjsur.2018.08.011 |
| SSID | ssj0001916253 |
| Score | 2.2652023 |
| SecondaryResourceType | review_article |
| Snippet | Pancreatic ductal adenocarcinoma (PDAC) is highly malignant. While cancers in other organs have shown clear improvements in 5‐year survival, the 5‐year... Pancreatic ductal adenocarcinoma (PDAC) is highly malignant. While cancers in other organs have shown clear improvements in 5-year survival, the 5-year... Abstract Pancreatic ductal adenocarcinoma (PDAC) is highly malignant. While cancers in other organs have shown clear improvements in 5‐year survival, the... |
| SourceID | doaj pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 7 |
| SubjectTerms | Biomarkers Blood vessels CA19‐9 Cancer therapies Chemotherapy conversion surgery Medical prognosis Metastasis minimally invasive pancreatectomy Minimally invasive surgery Mortality neoadjuvant treatment Pancreatic cancer resectability criteria Review Surgery Tomography |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pj9QgFCZmT3sxml21uhqMXjSpQ4Hyw9tqdt2Y6EU32VsDb0CbaDuZzvz_-6DdZiZO9OKFNIUQeDze-4DHByGvveeiVmDLCMDSAiWWRspQRvTF4FxgLpO4fvmqrq7l55v6ZueprxQTNtIDj4JbWO-lC-hmArdSYIKAHYxiUUsFlcvspcyyncVU3l1B1MNrMfOR8oX7MYh3aKZTzNaOB8pE_YfQ5Z9BkrvgNXufywfk_gQb6fnY3IfkXuhOSHsxpKtDqEF0u0or94GiozULTOx7OjEv0U2_amGgbUcR69Fhu862js4R5rSPFE3CiB6BJv5XzHZoj9DNraHt-t_ulFxfXnz_eFVOTyeUoAS3ZTrN09rHoKEKddC6siYsaxcR_lmfYAoL2isbDYC3fKksD9aA1CroWBkQj8hR13fhCaFaKSeXDBc-Hic4JA5F0BVgeVjqKqqCvLkTZwMTr3h63uJXMzIi8yaJvsmiL8iruexqZNM4WOpDGpW5RGLAzj9QL5pJL5p_6UVBzu7GtJmm5dBwaZjg2CN1OFubdCcDEVZBXs7ZON_SIYrrQr_NVSAIVNawgjweNWRuqBA1omGNles93dnryX5O1_7MnN4aLatV2Oq3Wcv-Ip3m_NM3kb-e_g85PSPHPIXp5F2lM3K0WW_Dc8RZG_8iT6lb7Wkj8g priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Ni9QwFA-6XryI4ld1lYheFOq0SZoPL7LKrougF12YW0lek7Wg7Tid-f99STvdHRz2UkoTQvPyPn5JXn4h5I1zjFcSTB4AijhBCbkWwucBYzFY6wubSFy_fZfnF-LrslpOC27DlFa584nJUTc9xDXyBRO64Ewh2v64-pvHW6Pi7up0hcZtcidRl6E-q6W6WmNB7MMqPrOSsoW9HPh7dNYxc-taHEp0_Ycw5v-pktchbIpBZ_fJvQk80pNxtB-QW757SNrTIR4gQj2i21Wcvw8Uw61e4MN8oBP_Et30qxYG2nYUER8dtuvk8eicZ077QNExjBgSaGSBxWKLXgmD3Rrarv9jH5GLs9Ofn8_z6QKFHCRnJo97ekq54BWUvvJKlUb7prIBQaBxEawUXjlpggZwhjXSMG80CCW9CqUG_pgcdX3nnxKKgreiKXD649DMITIpgioB60OjyiAz8nYnzhomdvF4ycXveuRFZnUUfZ1En5HXc93VyKlxsNanOCpzjciDnT7068t6MqvaOCesRxDimREcHzjeoGURlJBQ2iojx7sxrSfjHOorVTpcrHQ8mYE4KyOv5mK0uriVYjvfb1MTCAWl0UVGnowaMv8o5xViYoWNqz3d2evJfknX_krM3gr9q5H41--Slt0gnfrkyw-e3p7d3MXn5C6LaThp1eiYHG3WW_8CcdTGvUzG8g9YxhwU priority: 102 providerName: ProQuest |
| Title | Essential updates 2018/2019: Current topics in the surgical treatment of pancreatic ductal adenocarcinoma |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fags3.12379 https://www.ncbi.nlm.nih.gov/pubmed/33532676 https://www.proquest.com/docview/2480327666 https://www.proquest.com/docview/2786743554 https://www.proquest.com/docview/2486156980 https://pubmed.ncbi.nlm.nih.gov/PMC7832965 https://doaj.org/article/9bb4ae415e2943e29625c860f746c1a5 |
| Volume | 5 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bi9QwFA7r7osvonirrkNEXxTqtGmai_iyK7MugsuiLsxbSc4ka0HbYTrz_z1JOx0HB8GXUJrTksu5fLl9IeS1tawoBejUA2RhgOJTxblLPcZiMMZlJpK4frkSlzf887ycH5EP27MwPT_EOOEWLCP662DgxnbTHWmoue2Kd-h3pb5DTsLZ2nBxA-PXuxkWRD4s0lAyLss0EMeN_KRsuvt8LyJF4v5DaPPvTZN_gtkYjS7uk3sDjKRnfb8_IEeueUjqWReOEqFG0c0yjOQ7ioFXTTHR7-nAxETX7bKGjtYNRexHu80q-j467jinrafoIno0CTTwwWK2Qf-EYW8FddP-Mo_IzcXs-8fLdLhKIQVRMJ2G1T0prXcSclc6KXOt3KI0HuGgtgG2ZE5aob0CsJothGZOK-BSOOlzBcVjcty0jXtKqBTC8EWGAyGLBg-BUxFkDigPC5l7kZA32-asYOAZD9dd_Kx6hmRWhaavYtMn5NUou-zZNQ5KnYdeGSUCI3Z80a5uq8HAKm0tNw7hiGOaF5hg34MSmZdcQG7KhJxu-7QazLSrGFeoFlgjcThbqnBGAxFXQl6O2Wh_YVHFNK7dxF8gKBRaZQl50mvIWNCiKBEdS_y53NOdvZrs5zT1j8jxLdHTaoGlfhu17B-tU519-lbEp2f_I_yc3GVhe06cTTolx-vVxr1AfLW2k2hGmMq5nJCT89nV9ddJnKv4DQytIgQ |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fb9MwELZG9wAvCMSvwAAj4AGk0MRJ7BgJoQ06OrZVCDZpb5l9cUYkSErTCvFP8TdydtJsFdXe9hJVtWUld-e7z_b5O0JeaM2ihIP0C4DALlAKP41j4xcYi0EpEyhH4no44ePj-PNJcrJB_i7vwti0yqVPdI46r8HukQ9ZnAYRE4i2309_-bZqlD1dXZbQaM1i3_z5jUu25t3eR9TvS8Z2R0cfxn5XVcAHHjHp24MuIXRhBIQmMULgstvkiSoQGUltI3hghOaySAG0ZDmXzMgUYsGNKMIUIhz3GtmM7Y3WAdncGU2-fD3f1UG0xZKo50FlQ3XWRG8wPNhcsQuRzxUIWIdq_0_OvAiaXdTbvUVudnCVbrf2dZtsmOoOKUeNvbKElksXU7tj0FAM8OkQH_It7Rif6LyeltDQsqKIMWmzmDkfS_vMdloXFF1Ri1qBWt5ZbFboBzG8zqCs6p_qLjm-EuHeI4OqrswDQlHVKs4DXHBpdCxguRtBhID9IRdhwT3yainODDo-c1tW40fWMjGzzIo-c6L3yPO-77Rl8Vjba8dqpe9hmbfdH_XsLOsmcia1jpVB2GOYjCN8oL4h5UEhYg6hSjyytdRp1rmDJjs33vXNIrV3QRDZeeRZ34zz3B7eqMrUCzcEgk8u08Aj91sL6V80ihJE4QIHFyu2s_Ilqy1V-d1xiQv06JLjW792VnaJdLLtT98i9-vh5Z_4lFwfHx0eZAd7k_1H5AazSUBuz2qLDOazhXmMKG6un3RTh5LTq56t_wD8W1nV |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkBAvCMRX2AAj4AGk0MRO7BgJocFWNgYTEkzqW3Au9qg0ktK0Qvxr_HWcnY-totrbXqKqPlnJff5sn-8IeVYUjKcCVGgBIrdAsWGWJCa0GItBaxNpX8T185HYP04-TtLJBvnb34VxaZW9T_SOuqzB7ZGPWJJFnElE2yPbpUV82R2_nf0KXQcpd9Lat9NoVeTQ_PmNy7fmzcEuyvo5Y-O9b-_3w67DQAiCMxW6Qy8pC2skxCY1UuIS3JSptoiSVOGieWRkIZTNAArFSqGYURkkUhhp4ww4znuFXJUc6dGW5ESe7e8g7mIpHyqispE-afgrDBQua-xcDPStAtbh2__TNM_DZx__xjfJjQ640p1W026RDVPdJtO9xl1eQh2my5nbO2gohvpshA_1mna1n-iink2hodOKItqkzXLuvS0dctxpbSk6pRa_AnUVaHFYo0fEQDuHaVX_1HfI8aWw9i7ZrOrK3CcUha6TMsKlV4EuBlwVR5AxID2UMrYiIC96dubQVTZ3DTZO87YmM8sd63PP-oA8HWhnbT2PtVTvnFQGCleD2_9Rz0_yzqRzVRSJNgiADFMJxwfKGzIRWZkIiHUakO1epnnnGJr8TI3XD8vM3QpBjBeQJ8MwWrw7xtGVqZd-CoShQmVRQO61GjK8KOcp4nGJk8sV3Vn5ktWRavrDVxWX6NuVwLd-6bXsAu7kOx--cv_rwcWf-JhcQxvNPx0cHW6R68xlA_nNq22yuZgvzUOEc4vikbcbSr5ftqH-Ax6mXJw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Essential+updates+2018%2F2019%3A+Current+topics+in+the+surgical+treatment+of+pancreatic+ductal+adenocarcinoma&rft.jtitle=Annals+of+gastroenterological+surgery&rft.au=Ishido%2C+Keinosuke&rft.au=Hakamada%2C+Kenichi&rft.au=Kimura%2C+Norihisa&rft.au=Miura%2C+Takuya&rft.date=2021-01-01&rft.issn=2475-0328&rft.eissn=2475-0328&rft.volume=5&rft.issue=1&rft.spage=7&rft.epage=23&rft_id=info:doi/10.1002%2Fags3.12379&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_ags3_12379 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2475-0328&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2475-0328&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2475-0328&client=summon |